Arcus Biosciences, Inc. - Common Stock (RCUS)

CUSIP: 03969F109

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock
Shares outstanding
122,470,452
Total 13F shares
25,809,690
Share change
-288,990
Total reported value
$234,896,496
Price per share
$9.10
Number of holders
73
Value change
-$672,043
Number of buys
40
Number of sells
27

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Alphabet Inc.
13F
Company
4.1%
5,049,786
$40,146,000 30 Jun 2019
13F
Peter Svennilson
13F
Individual
2.9%
3,540,850
$28,150,000 30 Jun 2019
13F
BVF INC/IL
13F
Company
2.9%
3,535,223
$28,105,000 30 Jun 2019
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
2.2%
2,650,209
$21,069,000 30 Jun 2019
13F
BlackRock Finance, Inc.
13F
Company
1.8%
2,236,133
$17,777,000 30 Jun 2019
13F
EcoR1 Capital, LLC
13F
Company
1.2%
1,488,205
$11,787,000 30 Jun 2019
13F
Foresite Capital Management III, LLC
13F
Company
1.1%
1,366,973
$10,867,000 30 Jun 2019
13F
VANGUARD GROUP INC
13F
Company
0.89%
1,092,421
$8,685,000 30 Jun 2019
13F
STATE STREET CORP
13F
Company
0.5%
611,113
$4,858,000 30 Jun 2019
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.41%
507,529
$4,035,000 30 Jun 2019
13F
JPMORGAN CHASE & CO
13F
Company
0.42%
515,262
$3,983,000 30 Jun 2019
13F
HHLR ADVISORS, LTD.
13F
Company
0.35%
425,000
$3,379,000 30 Jun 2019
13F
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
13F
Company
0.28%
342,128
$2,720,000 30 Jun 2019
13F
Aisling Capital Management LP
13F
Company
0.27%
333,333
$2,650,000 30 Jun 2019
13F
NORTHERN TRUST CORP
13F
Company
0.27%
332,256
$2,642,000 30 Jun 2019
13F
Artal Group S.A.
13F
Company
0.22%
270,000
$2,147,000 30 Jun 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.19%
230,355
$1,831,000 30 Jun 2019
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.12%
146,193
$1,162,000 30 Jun 2019
13F
Nuveen Asset Management, LLC
13F
Company
0.11%
133,493
$1,061,000 30 Jun 2019
13F
BAKER BROS. ADVISORS LP
13F
Company
0.1%
121,534
$966,000 30 Jun 2019
13F
Bank of New York Mellon Corp
13F
Company
0.1%
116,963
$930,000 30 Jun 2019
13F
MORGAN STANLEY
13F
Company
0.08%
98,806
$785,000 30 Jun 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.08%
97,127
$773,000 30 Jun 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.08%
92,715
$737,000 30 Jun 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.06%
77,736
$618,000 30 Jun 2019
13F
CITADEL ADVISORS LLC
13F
Company
0.06%
69,537
$553,000 30 Jun 2019
13F
BARCLAYS PLC
13F
Company
0.04%
50,561
$402,000 30 Jun 2019
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.04%
49,123
$391,000 30 Jun 2019
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.04%
47,491
$378,000 30 Jun 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.04%
46,055
$366,000 30 Jun 2019
13F
MML INVESTORS SERVICES, LLC
13F
Company
0.04%
44,946
$357,000 30 Jun 2019
13F
RHUMBLINE ADVISERS
13F
Company
0.04%
44,199
$351,000 30 Jun 2019
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.04%
43,883
$349,000 30 Jun 2019
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.04%
43,300
$344,000 30 Jun 2019
13F
Swiss National Bank
13F
Company
0.04%
43,200
$343,000 30 Jun 2019
13F
BAILARD, INC.
13F
Company
0.03%
38,300
$304,000 30 Jun 2019
13F
DEUTSCHE BANK AG\
13F
Company
0.03%
37,261
$294,000 30 Jun 2019
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.03%
34,600
$275,000 30 Jun 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.03%
34,117
$272,000 30 Jun 2019
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.03%
31,200
$248,000 30 Jun 2019
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.02%
28,300
$225,000 30 Jun 2019
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
22,027
$175,000 30 Jun 2019
13F
Cubist Systematic Strategies, LLC
13F
Company
0.02%
20,494
$163,000 30 Jun 2019
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.02%
20,443
$163,000 30 Jun 2019
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.02%
20,050
$159,000 30 Jun 2019
13F
White Pine Investment CO
13F
Company
0.02%
18,939
$151,000 30 Jun 2019
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.01%
18,076
$144,000 30 Jun 2019
13F
PDT Partners, LLC
13F
Company
0.01%
16,700
$133,000 30 Jun 2019
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.01%
16,243
$129,000 30 Jun 2019
13F
Russell Investments Group, Ltd.
13F
Company
0.01%
16,037
$128,000 30 Jun 2019
13F

Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q3 2019

As of 30 Sep 2019, Arcus Biosciences, Inc. - Common Stock (RCUS) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,809,690 shares. The largest 10 holders included Alphabet Inc., BVF INC/IL, Svennilson Peter, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, HILLHOUSE CAPITAL ADVISORS, LTD., EcoR1 Capital, LLC, STATE STREET CORP, and JPMORGAN CHASE & CO. This page lists 73 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders
76
Q3 2019 holders
73
Holder diff
-3
Investor Q2 2019 Shares Q3 2019 Shares Share Diff Share Chg % Q2 2019 Value $ Q3 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.